Purchase Order 75D30121P12835
Award Date
9/27/21
Potential Completion Date
9/25/25
Potential Value
$54K
Federal Agency
CDC Pittsburgh
Awardee
Biolytic Lab Performance Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the procurement of a DR. OLIGO Synthesizer. The contract, valued at $84,950.00, has an ultimate completion date of April 30, 2020. Biolytic Lab Performance Inc. is a federal contractor that specializes in DNA synthesis solutions and laboratory equipment, and has secured multiple awards from various civilian and...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order, contract number 75D30120P09399, to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for a maintenance agreement covering a Biolytic DNA synthesizer. The $28,100 contract has an ultimate completion date of August 16, 2023. The contract was awarded without a set-aside on August 17, 2020, based on a sole-source solicitation. Biolytic Lab Performance is the only company...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned, for-profit organization that specializes in DNA synthesis solutions. The contract, valued at $56,000.00, is for the maintenance of Biolytic's DR. OLIGO 48 DNA synthesizers. The contract has a completion date of February 9, 2026. Biolytic Lab Performance Inc. has extensive experience providing DNA synthesizers, related instruments,...
This is a $95,700 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit company specializing in DNA synthesis solutions and laboratory equipment. The contract is for the procurement of a DR.OLIGO 48 DNA synthesizer, which allows the CDC to synthesize oligonucleotides at a much higher capacity with reduced turnaround time and argon gas consumption. This sole-source contract is based...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded Biolytic Lab Performance Inc., a for-profit, veteran-owned business, a firm-fixed-price purchase order contract for $42,600.00. The contract is for an annual service agreement with a completion date of August 9, 2025. The original solicitation was for 500 mL of Avantor Seradigm Premium Grade Fetal Bovine Serum. This contract does not have a set-aside designation. Biolytic Lab Performance...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit organization. The contract, valued at $84,950.00, is for the provision of an OLIGO INST (oligonucleotide instrument), with a performance period ending on July 20, 2021. The contract has no set-aside designation. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions and laboratory equipment, having secured...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $142,275.95 firm fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer of scientific equipment and tools for biomedical research and genetic analysis. The contract is for the delivery of a Life Technology Genetic Analyzer, with a completion date of July 27, 2020. Life Technologies has previously supplied specialized products, such as reagents, instruments, and...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a privately held company specializing in oligonucleotide-based tools. The contract, valued at $87,500.00, is for the provision of laboratory equipment. Biosearch Technologies has a history of providing laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for the provision of lab supplies. The contract has a potential value of $236,049.95 and a completion date of July 31, 2023. This award was not set aside for any specific business size or type. As a division of Thermo Fisher Scientific, Life...
This is a firm fixed price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Life Technologies Corporation, a manufacturer of scientific instruments and reagents, for the purchase of a capillary DNA sequencer. The contract has a potential value of $149,990.00 and a completion date of September 15, 2018. The contract was awarded on August 17, 2018 and does not have a set-aside designation. Life Technologies Corporation has served as a...